|
2-deoxyglucose-based dendrimer nanomedicine for the treatment of prostate cancer
Unmet Need: Highly Effective and Selective Drug Delivery Methods for Advanced-Stage Prostate Cancer Treatment
Prostate cancer is the second leading cause of cancer-related deaths among men in the United States, with advanced cases requiring urgent treatment. Current therapies offer only limited survival benefits, and many chemotherapies cause severe...
Published: 1/27/2025
|
Inventor(s): Anjali Sharma, Clifford Berkman
Keywords(s):
|
|
Targeted Drug Delivery Solutions for Advanced Prostate Cancer
Unmet Need: Highly Effective and Selective Drug Delivery Methods for Advanced-Stage Prostate Cancer Treatment
Prostate cancer is the second leading cause of cancer-related deaths among men in the United States, with advanced cases requiring urgent treatment. Current therapies offer only limited survival benefits, and many chemotherapies cause severe...
Published: 10/30/2024
|
Inventor(s): Anjali Sharma, Clifford Berkman
Keywords(s):
|
|
Acid Labile Linker for Cancer-Targeted Drug-Conjugates
AbstractControlled chemical release is an increasingly critical characteristic in targeted therapy. Controlling chemical release via selective drug delivery has been the focus of significant research efforts to reduce off target effects associated with therapy, especially with regards to cancer chemotherapy. In many controlled release applications,...
Published: 10/8/2024
|
Inventor(s): Clifford Berkman, Corinne Ley, Jonathan (jon) Geruntho, Cindy Choy
Keywords(s):
|